首页> 外文期刊>International heart journal >Knockdown of miR-665 Protects Against Cardiomyocyte Ischemia/Reperfusion Injury-Induced ROS Accumulation and Apoptosis Through the Activation of Pak1/Akt Signaling in Myocardial Infarction
【24h】

Knockdown of miR-665 Protects Against Cardiomyocyte Ischemia/Reperfusion Injury-Induced ROS Accumulation and Apoptosis Through the Activation of Pak1/Akt Signaling in Myocardial Infarction

机译:miR-665的敲低保护心肌细胞缺血/再灌注损伤诱导的ROS积聚和细胞凋亡通过在心肌梗死中的激活激活

获取原文
           

摘要

Myocardial infarction (MI) is one of the major causes of death worldwide, and the therapeutic strategies of MI are still limited. In this study, we investigated the function of miR-665 in MI. In the present study, an ischemia/reperfusion (I/R) rat model and a hypoxia/reoxygenation (H/R)-induced H9c2 cell model were successfully established to mimic the MI for in vivo and in vitro studies. The concentrations of lactate dehydrogenase (LDH), creatine kinase-MB (CK-MB), tumor necrosis factor alpha (TNF-α), IL-6, and reactive oxygen species (ROS) were then measured. Moreover, cell viability and apoptosis were detected by MTT assay, TdT-mediated dUTP nick end labeling (TUNEL), and PI/FITC-annexin V assay. The binding of miR-665 and Pak1 was determined by luciferase assay. miR-665 was upregulated in I/R rats, and the overexpression of miR-665 significantly increased LDH, CK-MB, TNF-α, IL-6, and ROS concentrations and induced cell apoptosis, while knockdown of miR-665 had opposite results. Consistent with in vivo results, miR-665 induced cell apoptosis and ROS generation in H/R-treated H9c2 cells. More importantly, Pak1 was the target gene of miR-665, and knockdown of miR-665 depressed the accumulation of ROS and cell apoptosis by targeting Pak1 and promoting the phosphorylation of Akt, whereas knockdown of Pak1 could attenuate the protection of miR-665 inhibitor in H/R-treated H9c2 cells. Therefore, knockdown of miR-665 protects against cardiomyocyte ischemia/reperfusion injury-induced ROS accumulation and apoptosis through activating Pak1/Akt signaling in MI. In general, understanding the biology and modulation of miR-665 may have the potential to counteract the development of MI.
机译:心肌梗死(MI)是全世界的主要死因之一,MI的治疗策略仍然有限。在这项研究中,我们研究了MIR-665在MI中的功能。在本研究中,成功​​地建立了一种缺血/再灌注(I / R)大鼠模型和缺氧/释放(H / R)诱导的H9C2细胞模型,以模拟体内和体外研究的MI。然后测量乳酸脱氢酶(LDH),肌酸激酶-MB(CK-MB),肿瘤坏死因子α(TNF-α),IL-6和反应性氧物质(ROS)的浓度。此外,通过MTT测定,TDT介导的DUTP缺口末端标记(TUNEL)和PI / FITC-ANNEXIN V测定检测细胞活力和细胞凋亡。通过荧光素酶测定法测定miR-665和pak1的结合。 MiR-665在I / R大鼠中上调,MiR-665的过表达显着增加LDH,CK-MB,TNF-α,IL-6和ROS浓度,诱导细胞凋亡,而MIR-665的敲低相反表达结果。与体内结果一致,MIR-665诱导细胞凋亡和ROS在H / R处理的H9C2细胞中产生。更重要的是,PAK1是MIR-665的靶基因,MIR-665的敲低通过靶向PAK1并促进AKT的磷酸化抑制ROS和细胞凋亡的积累,而PAK1的敲低可以衰减miR-665抑制剂的保护在H / R处理的H9C2细胞中。因此,MIR-665的敲低通过激活MI中的PAK1 / AKT信号传导来保护miR-665的敲低来保护心肌细胞缺血/再灌注损伤诱导的ROS积累和细胞凋亡。一般而言,了解MIR-665的生物学和调制可能有可能抵消MI的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号